Relmada Therapeutics Appoints Michael Becker as Senior Vice President of Finance and Corporate Development

By WebmasterNovember 4, 2014November 1st, 2024No Comments

Relmada Therapeutics Appoints Michael Becker as Senior Vice President of Finance and Corporate Development
Read more here

Previous PostNovira Therapeutics Announces Presentation of Phase Ia Safety and Pharmacokinetic Data for NVR 3-778
Next PostRelmada Therapeutics Reinforces Balance Sheet with $15.2 Million from Exercise of Warrants